ClinicalTrialsFinder
RecruitingNCT04367857

ARMOR Study: COVID-19 Seroprevalence Among Healthcare Workers

SARS-CoV-2 Seroprevalence Among Healthcare Workers: ARMOR Study Demonstration Project

Sponsor

Columbia University

Enrollment

1,000 participants

Start Date

Apr 18, 2020

Study Type

OBSERVATIONAL

Conditions

CoronavirusCOVID-19Coronavirus Infection

Summary

The novel coronavirus (SARS-CoV-2) has spread all around the world and testing has posed a challenge globally. Health care providers are highly exposed and are an important group to test. On top of these concerns, health care workers are also stressed by the needs on responders in the COVID-19 crisis. The investigators will look at different ways to measure how common COVID-19 is among health care workers, how common is the presence of antibodies by serological tests (also known as serostatus). The investigators will describe health worker mental and emotional well-being and their coping strategies in their institutional settings. Lastly, the investigators will describe how knowing serostatus can affect individuals' mental and emotional well-being and how to cope in the midst of the COVID-19 response. This will help to how to better test and help healthcare workers in the COVID-19 pandemic and prepare for possible future outbreaks.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

The ARMOR study is looking at how many healthcare workers at NewYork-Presbyterian Hospital were exposed to and developed antibodies against COVID-19 (SARS-CoV-2). This type of study is called a seroprevalence study — it measures the proportion of people in a group who have antibodies indicating past infection. Understanding how widespread COVID-19 exposure was among hospital staff can help improve infection control policies and protect healthcare workers in future outbreaks. Participants in this study provided blood samples to be tested for COVID-19 antibodies. The results help track real-world exposure rates among frontline workers, who faced particularly high risk during the pandemic. You may be eligible if: - You are 18 years or older - You are an employee or affiliate of NewYork-Presbyterian hospital - You can read and understand English You may NOT be eligible if: - You are under 18 years old - You are mentally or physically unable to complete the study requirements Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERCOVID-19 Serology

Quantitate Serology enzyme-linked immunosorbent assay (ELISA) for COVID-19

BEHAVIORALHealth Care Worker Survey

The purpose of this survey is to assess how healthcare workers are experiencing and coping with the COVID-19 crisis.

Locations(1)

NewYork-Presbyterian Hosptial/Columbia University Irving Medical Center

New York, New York, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04367857

Related Trials

Analysis of Suicidal Behavior Among Children and Adolescents in the Auvergne-Rhone-Alpes Region During the Covid 19 Pandemic Period

NCT073022954 locations

A Study Evaluating MDX2301 in Healthy Adults and Adults at Higher Risk for Severe COVID-19.

NCT074459712 locations

Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study

NCT0380892267 locations

A Study to Evaluate the Immunogenicity and Safety of mRNA-1283 COVID-19 Variant-containing Formulations

NCT070897065 locations

A Safety and Immunogenicity Trial of Boost-2867 Vaccine, Via Intranasal and Intramuscular Routes

NCT072211628 locations